VHL mosaicism: the added value of multi-tissue analysis
- PMID: 35304467
- PMCID: PMC8933488
- DOI: 10.1038/s41525-022-00291-3
VHL mosaicism: the added value of multi-tissue analysis
Abstract
Von Hippel-Lindau disease (VHL) is an autosomal dominant, inherited syndrome with variants in the VHL gene causing predisposition to multi-organ benign and malignant neoplasms. A germline VHL variant is identified in 95-100% of individuals with a clinical diagnosis of VHL. Here, we present the case of an individual with a clinical diagnosis of VHL disease where peripheral blood DNA analysis did not detect a VHL variant. Sequencing of four tumor tissues (ccRCC, pheochromocytoma, lung via sputum, liver) revealed a VHL c.593 T > C (p.Leu198Pro) variant at varying allele fractions (range: 10-55%) in all tissues. Re-examination of the peripheral blood sequencing data identified this variant at 6% allele fraction. Tumor analysis revealed characteristic cytomorphological, immunohistochemical reactivity for alpha-inhibin, and CAIX, and reduced pVHL reactivity supported VHL-related pseudohypoxia. This report of a rare case of VHL mosaicism highlights the value of tissue testing in VHL variant negative cases.
© 2022. The Author(s).
Conflict of interest statement
J.G. and E.C. are employed by Ambry Genetics. The remaining authors declare no competing interests.
Figures
References
-
- Kim, J. J., Rini, B. I. & Hansel, D. E. in Diseases of DNA Repair (ed. Ahmad, S. I.) 228–249 (Springer New York, 2010).
-
- Binderup MLM, et al. Von Hippel-Lindau disease (vHL). National clinical guideline for diagnosis and surveillance in Denmark. 3rd edition. Dan. Med. J. 2013;60:B4763. - PubMed
LinkOut - more resources
Full Text Sources
